Contact
searchSearch
HMP Global
Quiz

Making Sense of HECSI Scores in Trials

Riya Gandhi, MA
07/15/2025

Related Content

NEA Approved Features
Supporting the Transition to Self- Managed Care in Adolescents and Young Adults With Atopic Dermatitis
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
Dr Guttman
Conference Coverage
Chronic Hand Eczema: From Pathogenic Subtypes to Targeted JAK and IL-4/13 Therapy
02/20/2026
Riya Gandhi, MA
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic hand eczema, highlighting delgocitinib cream, ruxolitinib, gusacitinib, dupilumab, tralokinumab, and biomarker-driven Th1/Th2/Th17 endotypes.
A clinical update on chronic...
02/20/2026
The Dermatologist
Dr Glick
Conference Coverage
Rethinking Seborrheic Dermatitis in 2026: PDE4 Inhibitors, Luliconazole, and Microbiome-Driven Care
02/19/2026
Riya Gandhi, MA
A clinical update on seborrheic dermatitis, featuring roflumilast foam, luliconazole shampoo, JAK inhibitors, biologics, and microbiome-targeted therapies.
A clinical update on seborrheic dermatitis, featuring roflumilast foam, luliconazole shampoo, JAK inhibitors, biologics, and microbiome-targeted therapies.
A clinical update on seborrheic...
02/19/2026
The Dermatologist
NEA Approved Features
Patient Self-Monitoring and Shared Decision-Making in Atopic Dermatitis
12/09/2025
Jessica Garlewicz
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to progress toward different treat-to-target and other shared treatment goals with patients, self-monitoring can be integral to support this evolving care framework.
As eczema care continues to...
12/09/2025
The Dermatologist

Popular Articles

AD
News
Efficacy of Targeted Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Network Meta-Analysis
06/15/2024
Riya Gandhi, MA
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in...
06/15/2024
The Dermatologist
NRS Approved Features
Establishing a Core Domain Set for Rosacea Clinical Trials
08/05/2024
Riya Gandhi, MA
A recent consensus statement addresses the need for standardized outcome measures in clinical trials involving patients with rosacea.
A recent consensus statement addresses the need for standardized outcome measures in clinical trials involving patients with rosacea.
A recent consensus statement...
08/05/2024
The Dermatologist
acne
News
Therapeutic Relevance of Sebum in the Pathophysiology of Acne Vulgaris
09/19/2024
Jessica Garlewicz
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in...
09/19/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
Hausauer
Conference Coverage
Exploring Platelet-Rich Plasma in Dermatology
05/11/2024
Riya Gandhi, MA
In her session, “Platelet-Rich Plasma in Dermatology,” presented at Spring Dermatology Week 2024, Dr Amelia Hausauer illuminated the landscape of platelet-rich plasma in dermatology.
In her session, “Platelet-Rich Plasma in Dermatology,” presented at Spring Dermatology Week 2024, Dr Amelia Hausauer illuminated the landscape of platelet-rich plasma in dermatology.
In her session, “Platelet-Rich...
05/11/2024
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use